Telehealthcare MTM for Asthma
(MATCH Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if telehealth (online healthcare) and video support help young people with asthma adhere better to their inhaler routine. Participants will use either an electronic self-management tool alone or in combination with video healthcare support to enhance adherence to their inhaled corticosteroid (ICS) treatment. The trial targets individuals aged 12 to 35 with poorly controlled asthma, who often experience symptoms such as frequent asthma attacks or nighttime awakenings, and already use an emergency inhaler. Participants must have a smartphone and reliable internet access to join the study. As an unphased trial, this study offers a unique opportunity to explore innovative asthma management tools and potentially improve health routines.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, you must be using an inhaled corticosteroid (ICS) and a specific type of rescue inhaler to participate.
What prior data suggests that these methods are safe for adolescents and young adults with asthma?
Research has shown that inhaled corticosteroids (ICS) are safe and effective for treating asthma. These medications are widely used and have a strong safety record when used as directed. Most people experience few side effects, which are usually mild, such as a sore throat or hoarse voice.
Studies have found that telemedicine, including the Medication Therapy Management Video Telehealthcare, can improve asthma management by enhancing adherence to medication plans. This method has not introduced any new safety issues. It uses digital tools to track and remind patients about their medication.
Overall, both ICS treatment and telemedicine tools have proven safe. They help manage asthma more effectively without introducing new risks.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative approaches to managing asthma through telehealth. The trial combines Medication Therapy Management (MTM) with Electronic Adherence Self-Management (EAM), introducing a more personalized and convenient way for patients to manage their condition. Unlike traditional asthma treatments that primarily rely on in-person visits and manual adherence tracking, this method leverages video telehealth to deliver therapy and digital tools to monitor medication adherence. By integrating technology, this approach aims to enhance patient engagement and improve outcomes, potentially setting a new standard for asthma care.
What evidence suggests that this trial's treatments could be effective for asthma?
Research has shown that telemedicine can significantly aid in managing asthma. Studies have found that telemedicine makes it easier for individuals to control asthma symptoms, improves quality of life, and enhances adherence to treatment plans. For young people with asthma, telemedicine proves especially useful in managing their condition and tracking symptoms. This trial will compare two approaches: one group will use Electronic Adherence Self-Management (EAM) only, while another group will use Medication Therapy Management Video Telehealthcare plus EAM (MTM-EAM). These telehealth services can help teenagers and young adults adhere more consistently to their inhaled corticosteroid (ICS) treatments, potentially leading to better asthma control.46789
Who Is on the Research Team?
Kathryn Blake, PharmD
Principal Investigator
Nemours Children's Specialty Care
Robert Wise, MD
Principal Investigator
Johns Hopkins School of Medicine
Janet Holbrook, PhD
Principal Investigator
Johns Hopkins Bloomberg School of Public Health
Are You a Good Fit for This Trial?
This trial is for young adults aged 12-35 with uncontrolled asthma and poor medication adherence. Participants must have an Asthma Control Test score ≤19 or experience significant symptoms, use a compatible inhaler, speak English or Spanish, and be able to engage in telehealthcare.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Medication Therapy Management Video Telehealthcare plus Electronic Adherence Self-Management or Electronic Adherence Self-Management alone
Follow-up
Participants are monitored for adherence and asthma exacerbations using Propeller sensors and bi-weekly assessments
What Are the Treatments Tested in This Trial?
Interventions
- Electronic Adherence Self-Management (EAM)
- Inhaled corticosteroid (ICS)
- Medication Therapy Management (MTM) Video Telehealthcare
Trial Overview
The MATCH study tests if Telehealthcare Medication Therapy Management (MTM) via video calls and Electronic Adherence Self-Management (EAM) can improve medication adherence in adolescents and young adults with poorly controlled asthma.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Medication Therapy Management Video Telehealthcare plus Electronic Adherence Self-Management \[MTM-EAM\]
Electronic Adherence Self-Management \[EAM\] only
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
Nemours Children's Health System
Collaborator
American Lung Association
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Published Research Related to This Trial
Citations
Efficacy of Telemedicine for the Management of Asthma
The use of telemedicine positively affects asthma management by improving symptom control, patients' quality of life, and adherence to the treatment program.
Impact of Telemedicine on Asthma Control and Quality of Life ...
In pediatric asthma, telemedicine offers the possibility to reinforce self-management, monitor symptoms remotely and improve adherence to ...
Telemedicine and remote monitoring in asthma care
Telemedicine technology, pushed by the COVID-19 pandemic, has improved asthma management, notably treatment adherence.
Telehealth delivery of adherence and medication ...
The CASI trajectories suggest that interventions are most effective in improving asthma control in the initial three visits and less frequent ...
NCT03414177 | Telehealth Enhanced Asthma Management
An unfavorable change in the health of a participant, including abnormal laboratory findings, that happens during a clinical study or within a certain amount of ...
Using Telemedicine to Care for the Asthma Patient - PMC
In this review, best practices for starting a telemedicine asthma service with patients at home, distant clinic sites, and various other locations,
Asthma management in the digital age - PMC
Ever-improving digital tools for asthma assessment and treatment are key components of telemedicine platforms for asthma management.
Leveraging Telemedicine and Smartphones to Deliver ...
Models of SBTM for children with asthma include medication management, directly observed therapy, care coordination, and education. Results ...
Digital Health Technology in Asthma: A Comprehensive ...
Digital health interventions show substantial promise for asthma disease monitoring and personalization of treatment.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.